Ivermectin Evidence with Dr Tess Lawrie [1:00:44]

3 years ago     22
SFW

(131 MB)


0

0

0

0

0

WildKraken
19 Followers

Ivermectin Evidence with Dr Tess Lawrie https://www.youtube.com/watch?v=vYF8bnmdQfY Ivermectin reduces risk of death from COVID-19 -a rapid review & meta-analysis in support of the recommendation of Front Line COVID-19 Critical Care Alliance. https://www.researchgate.net/publication/348297284_Ivermectin_reduces_the_risk_of_death_from_COVID-19_-a_rapid_review_and_meta-analysis_in_support_of_the_recommendation_of_the_Front_Line_COVID-19_Critical_Care_Alliance_Latest_version_v12_-_6_Jan_2021 Review of the Emerging Evidence Demonstrating Efficacy of Ivermectin in Prophylaxis & Treatment of COVID-19 https://covid19criticalcare.com/wp-content/uploads/2020/11/FLCCC-Ivermectin-in-the-prophylaxis-and-treatment-of-COVID-19.pdf WHO model list of essential medicines - 2019 https://www.who.int/publications/i/item/WHOMVPEMPIAU2019.06 Ivermectin as Pre-exposure Prophylaxis for COVID-19 among Healthcare Providers in a Selected Hospital https://ejmed.org/index.php/ejmed/article/view/599 Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic https://www.researchsquare.com/article/rs-100956/v3 A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients. https://www.researchsquare.com/article/rs-38896/v1 Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients https://www.researchsquare.com/article/rs-109670/v1 Controlled randomized clinical trial on using Ivermectin wi Doxycycline for treating COVID-19 patients in Baghdad https://www.medrxiv.org/content/10.1101/2020.10.26.20219345v1 A five-day course ivermectin for treatment of COVID-19 may reduce duration of illness https://www.ijidonline.com/article/S1201-9712(20)32506-6/fulltext https://journal.chestnet.org/action/showPdf?pii=S0012-3692%2820%2934898-4 https://www.sciencedirect.com/science/article/abs/pii/S030028962030288X?via%3Dihub https://www.medrxiv.org/content/10.1101/2020.07.07.20145979v1


No Comments YetShare onShare on Poal